In our study, knockdown of the UGT1A10 gene in PDO_3 induce better tumor-killing effects for gemcitabine, paclitaxel, cisplatin, irinotecan, indicating that the expression of UGT1A10 affected drug sensitivity. Here, UGT1A10 is linked to neoplasm.